14-95116698-GAA-GAAAA

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP6_Very_Strong

The NM_177438.3(DICER1):​c.1510-5_1510-4dupTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000969 in 1,548,258 control chromosomes in the GnomAD database, with no homozygous occurrence. There is a variant allele frequency bias in the population database for this variant (GnomAdExome4), which may indicate mosaicism or somatic mutations in the reference population data. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000078 ( 0 hom. )

Consequence

DICER1
NM_177438.3 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.900

Publications

1 publications found
Variant links:
Genes affected
DICER1 (HGNC:17098): (dicer 1, ribonuclease III) This gene encodes a protein possessing an RNA helicase motif containing a DEXH box in its amino terminus and an RNA motif in the carboxy terminus. The encoded protein functions as a ribonuclease and is required by the RNA interference and small temporal RNA (stRNA) pathways to produce the active small RNA component that represses gene expression. This protein also acts as a strong antiviral agent with activity against RNA viruses, including the Zika and SARS-CoV-2 viruses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2021]
DICER1 Gene-Disease associations (from GenCC):
  • DICER1-related tumor predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • pleuropulmonary blastoma
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • DICER1 syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP6
Variant 14-95116698-G-GAA is Benign according to our data. Variant chr14-95116698-G-GAA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 696580.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_177438.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DICER1
NM_177438.3
MANE Select
c.1510-5_1510-4dupTT
splice_region intron
N/ANP_803187.1
DICER1
NM_001271282.3
c.1510-5_1510-4dupTT
splice_region intron
N/ANP_001258211.1
DICER1
NM_001291628.2
c.1510-5_1510-4dupTT
splice_region intron
N/ANP_001278557.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DICER1
ENST00000343455.8
TSL:1 MANE Select
c.1510-4_1510-3insTT
splice_region intron
N/AENSP00000343745.3
DICER1
ENST00000393063.6
TSL:1
c.1510-4_1510-3insTT
splice_region intron
N/AENSP00000376783.1
DICER1
ENST00000527414.5
TSL:1
c.1510-4_1510-3insTT
splice_region intron
N/AENSP00000435681.1

Frequencies

GnomAD3 genomes
AF:
0.0000273
AC:
4
AN:
146584
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000100
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000234
AC:
5
AN:
213306
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.000356
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000785
AC:
11
AN:
1401674
Hom.:
0
Cov.:
32
AF XY:
0.00000286
AC XY:
2
AN XY:
698278
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000348
AC:
11
AN:
31634
American (AMR)
AF:
0.00
AC:
0
AN:
42050
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25012
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38448
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83588
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50936
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5558
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1066618
Other (OTH)
AF:
0.00
AC:
0
AN:
57830
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.00000549320), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.384
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000273
AC:
4
AN:
146584
Hom.:
0
Cov.:
32
AF XY:
0.0000563
AC XY:
4
AN XY:
71090
show subpopulations
African (AFR)
AF:
0.000100
AC:
4
AN:
39894
American (AMR)
AF:
0.00
AC:
0
AN:
14730
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3410
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5102
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4628
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9180
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
310
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66416
Other (OTH)
AF:
0.00
AC:
0
AN:
2012
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

DICER1-related tumor predisposition Benign:1
Oct 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hereditary cancer-predisposing syndrome Benign:1
Mar 15, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.90
Mutation Taster
=99/1
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs546524688; hg19: chr14-95583035; API